Regeneron Pharmaceuticals Inc.

01/28/2022 | Press release | Distributed by Public on 01/28/2022 06:04

Regeneron and Sanofi Provide Regulatory Update on Libtayo® (cemiplimab-rwlc) in Advanced Cervical Cancer